Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet aggregation and in vivo shear forces

M M Mazeaud1, J Levenson, K H Le Quan Sang

  • 1Pharmacology, CNRS URA 1482, Faculté de Médecine Necker, Paris, France.

Thrombosis and Haemostasis
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Importance of prevention of infectious complications in pediatric hematologic-oncologic patients].

Klinische Padiatrie·2001
Same author

[Non-pharmacologic strategies to prevent and control infectious complications in pediatric hematology/oncology patients].

Klinische Padiatrie·2001
Same author

[Antimicrobial prophylaxis of bacterial infections in pediatric oncology patients].

Klinische Padiatrie·2001
Same author

Leukocyte filtration in cardiac surgery: a review.

Perfusion·2001
Same author

Preparation, crystal structure, and properties of barium pernitride, BaN(2).

Inorganic chemistry·2001
Same author

Molecular analysis of the mevalonate kinase gene in a cohort of patients with the hyper-igd and periodic fever syndrome: its application as a diagnostic tool.

Annals of internal medicine·2001

Hemodynamic shear forces influence platelet aggregation. In hypertensive patients, increased shear forces correlate with reduced platelet reactivity, suggesting a protective effect against clotting.

Area of Science:

  • Cardiovascular Physiology
  • Hematology
  • Pharmacology

Background:

  • Hemodynamic shear forces impact platelet function, with in vitro studies showing activation and in vivo studies indicating anti-aggregatory effects via endothelium-derived factors.
  • Hypertension is associated with altered blood flow dynamics and potentially modified platelet reactivity.
  • Understanding the interplay between shear forces and platelet behavior in hypertension is crucial for cardiovascular health.

Purpose of the Study:

  • To investigate the relationship between brachial artery hemodynamic shear forces and ex vivo platelet aggregatory response in hypertensive patients.
  • To assess how antihypertensive treatment affects these hemodynamic forces and subsequent platelet reactivity.
  • To determine if shear-dependent anti-aggregatory effects prevail over direct platelet activation in hypertensive individuals.

Related Experiment Videos

Main Methods:

  • Measurement of platelet reactivity (EC50 for ADP and collagen) and hemodynamic parameters (blood velocity, shear rate, shear stress) in hypertensive patients before and after 6 months of nitrendipine treatment.
  • Analysis of correlations between platelet aggregation and hemodynamic forces, controlling for confounding factors like age, BMI, blood pressure, lipids, and hematocrit.
  • Evaluation of platelet cytosolic Ca2+ and cyclic AMP levels.

Main Results:

  • Platelet reactivity inversely correlated with blood velocity, shear rate, and shear stress (p < 0.01).
  • These correlations were independent of age, BMI, blood pressure, lipids, hematocrit, platelet cytosolic Ca2+, and cyclic AMP.
  • Nitrendipine treatment improved shear forces and reduced platelet aggregation, maintaining the negative correlation between them.

Conclusions:

  • Shear-dependent anti-aggregatory effects, likely mediated by endothelium-derived factors, are significant in hypertensive patients.
  • These flow-mediated protective mechanisms appear to outweigh the direct platelet-activating effects of shear forces.
  • Antihypertensive therapy can modulate both hemodynamic forces and platelet reactivity, highlighting a potential therapeutic benefit beyond blood pressure reduction.